Edgewise Therapeutics (EWTX) net assets (shareholders' equity)

Net assets · fiscal 2025
$522.26M

Edgewise Therapeutics (EWTX) had net assets of $522.26M at the end of fiscal 2025 (December 31, 2025). That is 13.7% higher than the $459.22M of fiscal 2024. Figures as of 19 Nov 2026, 02:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$522.26M
Change on fiscal 2024
+13.7%
Highest on record
$522.26Mfiscal 2025
Lowest on record
-$33.42Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Edgewise Therapeutics net assets (shareholders' equity), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $522.26M in fiscal 2025 and the lowest -$33.42M in fiscal 2020.

History · 6 fiscal years

Net assets by fiscal year

Edgewise Therapeutics net assets (shareholders' equity), year by year

Edgewise Therapeutics (EWTX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$522.26M 13.7% up
2024$459.22M 44.0% up
2023$318.83M 8.0% down
2022$346.72M 26.4% up
2021$274.38M—
2020-$33.42M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Edgewise Therapeutics and comparable companies
CompanyNet assetsFiscal year
Concentra Group Holdings Parent CON$393.28M2025
Edgewise Therapeutics EWTX$522.26M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EWTX

Edgewise Therapeutics, figure by figure

Edgewise Therapeutics (EWTX) overview: price, valuation and scorecardAll health care companies by market value

Edgewise Therapeutics net assets (shareholders' equity): questions and answers

What are Edgewise Therapeutics's net assets?

Edgewise Therapeutics (EWTX) had net assets of $522.26M at the end of fiscal 2025 (December 31, 2025). That is 13.7% higher than the $459.22M of fiscal 2024.

What are the highest and lowest net assets figures on record for Edgewise Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $522.26M in fiscal 2025 and the lowest -$33.42M in fiscal 2020.

How is Edgewise Therapeutics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Edgewise Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/EWTX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.